The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer

Oncology Letters

Volumn 3, Issue 1, 2012, Pages 176-180

  Al Harithy, Rowyda N ^a   Al Zahrani, Maryam H ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Adiponectin; Colon cancer; Polymerase chain reaction; Restriction fragment length polymorphism; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN; GENOMIC DNA; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CANCER GENETICS; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855223723     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.443     Document Type: Article

References (32)

1. Ibrahim M, Zeeneldin A, El-Khodary T, Al-Gahmi A and Bin Sadiq B: Past present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol 14: 178-182, 2008.
2. Aljebreen A: Clinico-pathological patterns of colorectal cancer in Saudi Arabia: Younger with an advanced stage presentation. Saudi J Gastroenterol 13: 84-87, 2007.
3. Scherer P, Williams S, Fogliano M, Baldini G and Lodish H: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749, 1995.
4. Maeda K, Okubo K, Shimomura I, et al: Cdna cloning and expression of a novel adipose specific collagen-like factOR=apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221: 286-289, 1996.
5. Kadowaki T and Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451, 2005.
6. Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.
7. Weyer C, Funahashi T, Tanaka S, et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001.
8. Yamauchi T, Kamon J, Ito Y, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003.
9. Kondo H, Shimomura I, Matsukawa Y, et al: Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 51: 2325-2328, 2002.
10. Chandran M, Ciaraldi T, Phillips SA and Henry R: Adiponectin: more than just another fat cell hormone? Diabetes Care 26: 2442-2450, 2003.
11. Diez J and Iglesias P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148: 293-300, 2003.
12. Cruz M, García-Macedo R, García-Valerio Y, et al: Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 27: 1451-1453, 2004.
13. Engeli S, Feldpausch M, Gorzelniak K, et al: Association between adiponectin and mediators of inflammation in obese women. Diabetes 52: 942-947, 2003.
14. Kazumi T, Kawaguchi A, Sakai K, Hirano T and Yoshino G: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25: 971-976, 2002.
15. Ryo M, Nakamura T, Kihara S, et al: Adiponectin as a biomarker of the metabolic syndrome. Circ J 68: 975-981, 2004.
16. Ishikawa M, Kitayama J, Yamauchi T, et al: Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 98: 1120-1127, 2007.
17. Fukumoto J, Otake T, Tajima O, et al: Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 99: 781-786, 2008.
18. Kumor A, Daniel P, Pietruczuk M and Małecka-Panas E: Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 24: 275-281, 2009.
19. Hara K, Boutin P, Mori Y, et al: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51: 536-540, 2002.
20. Menzaghi C, Ercolino T, Di Paola R, et al: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51: 2306-2312, 2002.
21. Menzaghi C, Ercolino T, Salvemini L, et al: Multigenic control of serum adiponectin levels: evidence for a role of the ADIPOQ gene and a locus on 14q13. Physiol Genomics 19: 170-174, 2004.
22. Berthier MT, Houde A, Cote M, et al: Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men. J Lipid Res 46: 237-244, 2005.
23. Pollin T, Tanner K, O'Connell J, et al: Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the ADIPOQ gene. Diabetes 54: 268-274, 2005.
24. Qi L, Li T, Rimm E, et al: The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54: 1607-1610, 2005.
25. Melistas L, Mantzoros C, Kontogianni M, et al: Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in non-diabetic Greek women. Eur J Endocrinol 161: 845-852, 2009.
26. Siitonen N, Pulkkinen L, Lindström J, et al: Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 12: 5, 2011.
27. Jang Y, Lee J, Kim O, et al: The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin. Metabolism 55: 59-66, 2006.
28. Filippi E, Sentinelli F, Trischitta V, et al: Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 12: 199-205, 2004.
29. Ohashi K, Ouchi N, Kihara S, et al: Adiponectin I164 T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43: 1195-1200, 2004.
30. Vozarova de Courten B, Hanson R, et al: Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 54: 284-289, 2005.
31. Filippi E, Sentinelli F, Romeo S, et al: The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
32. Woo J, Dolan L, Deka R, et al: Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. Diabetes 55: 523-529, 2006.